ask="17.70"
ask_size="100"
average_daily_volume="973750"
bid="12.25"
bid_size="200"
book_value="0.00"
change="+0.05"
change_from_200_day_moving_average="-2.77"
change_from_50_day_moving_average="0.41"
change_from_52_week_high="-11.91"
change_From_52_week_low="1.34"
change_in_percent="+0.37%"
close="13.55"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.87"
ebitda="0.00"
eps_estimate_current_year="-4.51"
eps_estimate_next_quarter="-0.97"
eps_estimate_next_year="-4.01"
ex_dividend_date="N/A"
float_shares="N/A"
high="13.70"
high_52_weeks="25.46"
last_trade_date="2/10/2017"
last_trade_price="13.55"
last_trade_size="31774"
last_trade_time="4:00pm"
low="13.30"
low_52_weeks="12.21"
market_capitalization="N/A"
moving_average_200_day="16.32"
moving_average_50_day="13.14"
name="Heron Therapeutics
Inc."
notes="N/A"
one_year_target_price="30.75"
open="13.45"
pe_ratio="N/A"
peg_ratio="0.15"
percent_change_from_200_day_moving_average="-16.96%"
percent_change_from_50_day_moving_average="+3.12%"
percent_change_from_52_week_high="-46.78%"
percent_change_from_52_week_low="+10.97%"
previous_close="13.50"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="N/A"
short_ratio="0.00"
stock_exchange="NCM"
symbol="HRTX"
volume="468333"
weeks_range_52="12.21 - 25.46"
